New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Innovative Eyewear, Inc.
LUCY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

14M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

14M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

8.90USD
Shape1.40 ( 18.67%)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

-80%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

67%

Quote Panel

Shape
Updated October 3, 2024
1W 0.00 % 1M 88.16 % 3M 6.46 % 1Y -13.34 %

Key Metrics

Shape
  • Market Cap

    13.98M


  • Shares Outstanding

    1.57M


  • Share in Float

    258735


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    8.9


  • Average Volume

    1.68M


  • Beta

    2.747


  • Range

    3.26-27.2


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.lucyd.co


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.70x

P/S Ratio

1.07x

P/B Ratio

0.0

Debt/Equity

-514.1%

Net Margin

$-11.3

EPS

How LUCY compares to sector?

P/E Ratio

Relative Strength

Shape

LUCY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$14M

Shape4435%

2025-Revenue

$2.78

Shape-49%

2025-EPS

$14M

Shape-626%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.21
vs -0.18

Q4.22

arrow
arrow

N/A

-0.26
vs -0.19

Q1.23

arrow
arrow

N/A

-0.26
vs -0.17

Q2.23

arrow
arrow

N/A

-0.20
vs -0.20

Q3.23

arrow
arrow

N/A

-0.12
vs -0.21

Q4.23

arrow
arrow

N/A

-0.19
vs -0.26

Q1.24

arrow
arrow

N/A

-3.00
vs -0.26

Q2.24

arrow
arrow

N/A

-1.87
vs -0.20

Q3.24

arrow
arrow

N/A

-1.36
vs -0.12

Q4.24

arrow
arrow

N/A

-1.29
vs -0.19

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-11%

152K  vs 171K

Q4.22

arrow
arrow

-76%

67.1K  vs 275.5K

Q1.23

arrow
arrow

-39%

144.9K  vs 236K

Q2.23

arrow
arrow

-17%

169.9K  vs 204.7K

Q3.23

arrow
arrow

+46%

221.9K  vs 152K

Q4.23

arrow
arrow

+818%

615.8K  vs 67.1K

Q1.24

arrow
arrow

+165%

383.5K  vs 144.9K

Q2.24

arrow
arrow

+82%

308.7K  vs 169.9K

Q3.24

arrow
arrow

+306%

900K  vs 221.9K

Q4.24

arrow
arrow

+95%

1.2M  vs 615.8K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-25%

-0.25
vs 0.88

Q4.22

arrow
arrow

-47%

-0.47
vs -0.25

Q1.23

arrow
arrow

-31%

-0.31
vs -0.47

Q2.23

arrow
arrow

-14%

-0.14
vs -0.31

Q3.23

arrow
arrow

-20%

-0.20
vs -0.14

Q4.23

arrow
arrow

-43%

-0.43
vs -0.20

Q1.24

arrow
arrow

-51%

-0.51
vs -0.43

Q2.24

arrow
arrow

-27%

-0.27
vs -0.51

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News